Search results
Novavax Soars on $1.2 Billion Sanofi Vaccine Licensing Deal
Bloomberg via Yahoo Finance· 1 week ago(Bloomberg) -- Novavax Inc. shares surged after the company signed a $1.2 billion licensing...
Novavax stock doubles after Sanofi deal marks 'new chapter' for company
Yahoo Finance· 1 week agoNovavax struggled after its COVID-19 vaccine was delayed by manufacturing issues early in...
Novavax strikes $1.2 billion deal with Sanofi in major turnaround
Axios· 1 week agoThe French drug giant Sanofi is taking a minority stake in Novavax and entering into a licensing...
Novavax Stock Surges 140% on $1.4 Billion Deal With Sanofi
Barrons.com· 1 week agoSanofi agreed to pay $500 million upfront and spend another $700 million when the company hits...
Forget Nvidia: These 3 Small-Cap Stocks Offer Up to 557% Upside, According to Select Wall Street...
Motley Fool via Yahoo Finance· 2 weeks agoBioNTech raked in tens of billions of dollars in sales from proverbial low-hanging fruit with their...
Will your last COVID vaccine work against new ‘FLiRT’ variants?
WJZY via Yahoo News· 1 week agoUltimately, it depends on when you got your last dose. In fall, an updated COVID vaccine was...
FliRT, a group of COVID-19 variants, accounts for most US cases. How to stay safe
Delaware Online | The News Journal via Yahoo News· 2 days agoThe agency adds that there is no “preferential recommendation” for one COVID-19 vaccine over...
5 Things to Know: COVID-19 Vaccines for Immunocompromised People
Medscape· 4 days agoCDC experts share what clinicians should know about COVID-19 prevention in immunocompromised...
Elon Musk Breaks Ranks With GOP By Praising Genetic Engineering Tech That Helped Fight COVID-19:...
Benzinga· 2 weeks agoElon Musk has come off as a flagbearer of the mRNA technology, which is seen holding out a lot of...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 6 days agoThough it has a booster Covid shot, like rivals Moderna and Novavax, analysts don't expect sales to...